United States · FDA National Drug Code directory
Amoxicillin and Clavulanate Potassium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0093-8675_2faf9b29-5df4-4f3c-84d9-6866f91b87e8
- Product NDC
- 0093-8675
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- Amoxicillin and Clavulanate Potassium
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20040923
- Source listing expiry
- 20271231
Source-listed ingredients
- AMOXICILLIN — 600 mg/5mL
- CLAVULANATE POTASSIUM — 42.9 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 200 mL in 1 BOTTLE (0093-8675-74) · 0093-8675-74
- 125 mL in 1 BOTTLE (0093-8675-75) · 0093-8675-75
- 75 mL in 1 BOTTLE (0093-8675-78) · 0093-8675-78
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →